Saniona
saniona.com
Actively hiring
Drug Discovery
Artificial Intelligence
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Overview
Improving lives through scientific innovation. At Saniona, our vision is to improve the lives of rare disease patients around the world through scientific innovation.
News
Jazz Pharmaceuticals & Saniona Enter an Exclusive Licensing Agreement to Develop and Commercialize SAN2355 PharmExec
Jazz Pharmaceuticals partners with Saniona to develop SAN2355, a promising epilepsy treatment, enhancing options for neurological disorders.
Read more
Report
Privacy Notices
Privacy Notices Privacy Notices Privacy Notice - Saniona AB Privacy Notice - Saniona A/S Privacy Notice - Clinical Trial Participants
Read more
Report
Privacy Notice - Saniona A/S
Privacy Notice - Saniona A/S Privacy Notice - Saniona A/S PLACEHOLDER
Read more
Report
Privacy Notice - Saniona AB
Privacy Notice - Saniona AB Privacy Notice - Saniona AB Privacy Policy of Saniona AB We welcome your interest in Saniona AB's products and services. Saniona AB may collect personal data on visitors through this web site. By
Read more
Report
Saniona readies IND filing for rapid-acting oral antidepressant SAN2465
Tipranks Press Release.
Read more
Report
Privacy Notice - Clinical Trial Participants
Privacy Notice - Clinical Trial Participant Privacy Notice - Clinical Trial Participant PLACEHOLDER
Read more
Report
Saniona AB: Saniona completes toxicology and CMC studies for SAN2465, enabling IND submission by October 2026
Saniona (OMX: SANION), a clinical-stage biopharmaceutical company focused on neurological and psychiatric disorders, today announces the successful completion of the toxicology, chemistry, manufacturing
Read more
Report
Saniona completes toxicology and CMC studies for SAN2465, enabling IND submission by October 2026
Read more
Report
Analyst Coverage
INVESTORS Analyst Coverage Overview The Share Share Information Ownership Structure Financial Calendar Reports & Fillings Annual & Quarterly Reports Prospectus Old prospectus Analysts Events and Presentations FAQs Corporate governance Executive Team Board
Read more
Report
Show more news